Fig. 1
Economic impact (cost items), excluding the related costs for HCV therapy, in HIV+ and HIV/HCV populations, with one comorbidity
Fig. 1 | Health Economics Review
Economic impact (cost items), excluding the related costs for HCV therapy, in HIV+ and HIV/HCV populations, with one comorbidity